Advyzon Investment Management, LLC Acadia Pharmaceuticals Inc Transaction History
Advyzon Investment Management, LLC
- $452 Billion
- Q2 2025
A detailed history of Advyzon Investment Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Advyzon Investment Management, LLC holds 9,544 shares of ACAD stock, worth $234,782. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,544Holding current value
$234,782% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
354Shares Held
163MCall Options Held
1.8MPut Options Held
337K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.05 Billion8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$376 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$297 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$210 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$172 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.98B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...